[Immediate results of the comprehensive treatment of infectious forms of syphilis with erythromycin, bismuth and nonspecific preparations]. 1978

T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011749 Pyrogens Substances capable of increasing BODY TEMPERATURE and cause FEVER and may be used for FEVER THERAPY. They may be of microbial origin, often POLYSACCHARIDES, and may contaminate distilled water. Pyrogen
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D001729 Bismuth A metallic element that has the atomic symbol Bi, and atomic number 83. Its principal isotope is Bismuth 209.
D002601 Chancre The primary sore of syphilis, a painless indurated, eroded papule, occurring at the site of entry of the infection.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat

Related Publications

T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
April 1976, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
May 1981, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
September 1979, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
April 1970, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
August 1971, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
January 1972, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
February 1976, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
September 1973, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
August 1976, Vestnik dermatologii i venerologii,
T V Vasil'ev, and I N Vinokuriv, and G K Gracheva, and I A Ivanov, and L M Ovsiannikov
May 1974, Vestnik dermatologii i venerologii,
Copied contents to your clipboard!